- Home
- /
- News
- /
- Biotherapeutics
- /
- March 2021
Biotherapeutics News for March 2021
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant. IONTAS is now seeking development partners
26 March, 2021
Diverse panel of novel target binders from IONTAS / FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline
08 March, 2021